podophyllotoxin has been researched along with Carcinoma, Epidermoid in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 32 (71.11) | 18.7374 |
| 1990's | 1 (2.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (17.78) | 24.3611 |
| 2020's | 4 (8.89) | 2.80 |
| Authors | Studies |
|---|---|
| Altucci, L; Benedetti, R; Brogi, S; Butini, S; Campiani, G; Carullo, G; Casagni, A; De Matteis, A; Díaz, JF; Federico, S; Galatello, P; Gemma, S; Ghanim, M; Ibrahim, O; Kelly, VP; Khan, T; Lamponi, S; Lucena-Agell, D; Magnano, S; McCabe, N; Nathwani, S; O'Sullivan, J; Papulino, C; Pozzetti, L; Ramunno, A; Relitti, N; Staiano, L; Turkington, R; Ulivieri, C; Valoti, M; Vanni, F; VanWemmel, R; Zisterer, D | 1 |
| Enos, T; Leung, B; Vandergriff, T | 1 |
| Chae, JI; Jeon, YJ; Park, S; Seo, JH; Shim, JH; Yoon, G | 1 |
| Cho, SD; Choi, SJ; Shin, JA; Yu, HJ | 1 |
| Dyrager, C; Fryknäs, M; Gullbo, J; Lennartsson, J; Sooman, L; Wickström, M; Wu, X | 1 |
| Bailly, C; Bal-Mahieu, C; Bertheau, C; Chevalier, D; Gros, A; Horn, S; Lansiaux, A; Lartigau, E; Meignan, S; Mouawad, F; Rysman, B; Sarrazin, T | 1 |
| Bergqvist, M; Bergström, S; Brandén, E; Ekman, S; Harmenberg, J; Holgersson, G; Jerling, M; Klockare, M; Koyi, H; Larsson, O; Lundström, KL; Ringbom, M | 1 |
| Cherpelis, B; Rudnick, EW; Thareja, S | 1 |
| Chen, MC; Lee, KH; Li, TK; Pan, SL; Shi, Q; Teng, CM; Xiao, Z | 1 |
| Cao, B; Chen, H; Jiang, YG; Lü, JJ; Mei, X; Wu, KZ | 1 |
| Clayburgh, DR; Gross, ND; Koide, J; Proby, C; Wong, MH | 1 |
| Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, RA; Sonntag, RW | 1 |
| Hansen, HH; Pedersen, AG | 1 |
| Blessing, JA; Homesley, HD; Slayton, RE | 1 |
| Bellamy, AS; Hill, BT | 1 |
| Bains, M; Coonley, CJ; Dukeman, M; Heelan, R; Kelsen, DP | 1 |
| Klastersky, J; Longeval, E | 1 |
| Casper, ES; Chapman, RA; Golbey, RB; Gralla, RJ; Itri, LM; Kelsen, DP | 1 |
| Creagan, ET; Eagan, RT; Kvols, LK | 1 |
| Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, R; Kaplan, S; Obrecht, JP; Sonntag, R; Weber, W | 1 |
| Gemba, K; Kiura, K; Matsumura, T; Moritaka, T; Ohnoshi, T; Segawa, Y; Shibayama, T; Tabata, M; Takigawa, N; Ueoka, H | 1 |
| El-Morsi, B; El-Sebai, IT; Gad-el-Mawla, NM; Hamza, MR; Khafagy, M; Mansour, MA; Muggia, FM; Sherif, M | 1 |
| Baker, LH; Fraile, RJ; Samson, MK; Talley, RW | 1 |
| Cole, JR; Jolad, SD; Wiedhopf, RM | 1 |
| Creagan, ET; Eagan, RT; Frytak, S; Ingle, JN; Kvols, LK; McMachon, RT; Rubin, J | 1 |
| Brunner, KW; Cavalli, F; Hasler, E; Martin, J; Ryssel, HJ; Sonntag, RW; Tschopp, L | 1 |
| Amiel, JL; Baron, A; Huguenin, P; Laparre, Ch; Mathé, G; Morin, P; Parrot, R; Pouillart, P; Schwarzenberg, L | 1 |
| Chikata, E; Hara, K; Ito, F; Kado, M; Kanda, T; Matsui, Y; Nakayama, M; Ohshima, S; Sakai, S; Shimokata, K | 1 |
| Kimura, K; Niitani, H | 1 |
| Hara, K; Kado, M; Kanda, T; Matsui, Y; Oshima, S; Shima, K; Shimokata, K; Takenaka, S | 1 |
| Abad-Esteve, A; Fernandez, C; Monras, P; Moreno, I; Morera, J; Ribas-Mundo, M; Rosell, R; Ruiz, J | 1 |
| Bundy, BN; Muss, HB; Yazigi, R; Yordan, E | 1 |
| Christensen, IJ; Hansen, HH; Roed, H; Spang-Thomsen, M; Vindelov, LL | 1 |
| Anderson, G; Payne, H | 1 |
| Felman, IE; Gala, KV; Grunberg, SM; Johnson, KB; Owens, JC | 1 |
| BERNHARDT, H; DAWSON, DF; DUCKWORTH, JK; YOUNG, JM | 1 |
| Bilder, J; Hornová, J | 1 |
| Hornová, J; Kosut, V; Smékal, M | 1 |
| Anderson, JM; Hutchison, J | 1 |
| Harms, J; Heckmann, U; Tranckjer, AS | 1 |
| Grimmer, H | 1 |
| Bettley, FR | 1 |
| Busch, W; Goldschmidt, F | 1 |
| Garret, M | 1 |
2 review(s) available for podophyllotoxin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies.
Topics: Administration, Oral; Anilides; Antineoplastic Agents; Biphenyl Compounds; Capecitabine; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; ErbB Receptors; Erlotinib Hydrochloride; Fluorouracil; Gefitinib; Hedgehog Proteins; Molecular Targeted Therapy; Phthalazines; Podophyllotoxin; Pyridines; Quinazolines; Receptor, IGF Type 1; Retinoids; Skin Neoplasms; Tumor Burden | 2016 |
Etoposide (VP-16) in the treatment of lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Humans; Lung Neoplasms; Podophyllotoxin; Time Factors | 1983 |
5 trial(s) available for podophyllotoxin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
A phase I pilot study of the insulin-like growth factor 1 receptor pathway modulator AXL1717 in combination with gemcitabine HCl and carboplatin in previously untreated, locally advanced, or metastatic non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Pilot Projects; Podophyllotoxin; Prognosis; Receptor, IGF Type 1; Tissue Distribution | 2015 |
Chemotherapeutic management of carcinoma of the bilharzial bladder: a phase II trial with hexamethylmelamine and VM-26.
Topics: Adolescent; Adult; Aged; Altretamine; Carcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; Middle Aged; Podophyllotoxin; Schistosomiasis; Teniposide; Triazines; Urinary Bladder Diseases; Urinary Bladder Neoplasms | 1978 |
A randomized study comparing platinum, doxorubicin, and VP-16 with platinum, 4'-epidoxorubicin, and VP-16 in patients with non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Podophyllotoxin; Random Allocation | 1987 |
Response rate and toxicity of etoposide (VP-16) in squamous carcinoma of the lung: report from the Lung Cancer Treatment Study Group.
Topics: Carcinoma, Squamous Cell; Clinical Trials as Topic; Etoposide; Humans; Lung Neoplasms; Podophyllotoxin | 1985 |
Long-term chemotherapy for cancer of the lung.
Topics: Aged; Carcinoma, Squamous Cell; Catheterization; Clinical Trials as Topic; Fluorouracil; Humans; Injections, Intravenous; Long-Term Care; Lung Neoplasms; Male; Mechlorethamine; Methotrexate; Middle Aged; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum | 1968 |
38 other study(ies) available for podophyllotoxin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Design and synthesis of multifunctional microtubule targeting agents endowed with dual pro-apoptotic and anti-autophagic efficacy.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Squamous Cell; Cell Line, Tumor; Humans; Microtubules; Mouth Neoplasms | 2022 |
Podophyllotoxin Cytological Effects on the Epidermis in Condyloma Acuminatum.
Topics: Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Condylomata Acuminata; Diagnostic Errors; Epidermis; Female; Humans; Overtreatment; Podophyllotoxin; Vulvar Neoplasms | 2022 |
Deoxypodophyllotoxin Induces ROS-Mediated Apoptosis by Modulating the PI3K/AKT and p38 MAPK-Dependent Signaling in Oral Squamous Cell Carcinoma.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Drugs, Chinese Herbal; Flavonolignans; Head and Neck Neoplasms; Humans; Mouth Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Podophyllotoxin; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Squamous Cell Carcinoma of Head and Neck | 2022 |
Podophyllotoxin reduces the aggressiveness of human oral squamous cell carcinoma through myeloid cell leukemia‑1.
Topics: Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Leukemia; Mouth Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Myeloid Cells; Podophyllotoxin; Squamous Cell Carcinoma of Head and Neck | 2023 |
Alternative cytotoxic effects of the postulated IGF-IR inhibitor picropodophyllin in vitro.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Dose-Response Relationship, Drug; ErbB Receptors; Esophageal Neoplasms; Humans; Microtubules; Phosphorylation; Podophyllotoxin; Protein Kinase Inhibitors; Receptor, IGF Type 1; Signal Transduction; Tubulin Modulators | 2013 |
The antitumor drug F14512 enhances cisplatin and ionizing radiation effects in head and neck squamous carcinoma cell lines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Flow Cytometry; Fluorouracil; Humans; Laryngeal Neoplasms; Microscopy, Confocal; Pharyngeal Neoplasms; Podophyllotoxin; Tongue Neoplasms; Treatment Outcome | 2014 |
QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells.
Topics: Adenocarcinoma; Antigens, Neoplasm; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Caspase 3; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Flow Cytometry; Humans; Lung Neoplasms; Piperidines; Podophyllotoxin; Poly(ADP-ribose) Polymerases; RNA, Small Interfering; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2012 |
[Anti-MDR tumor mechanism of CIP-36, a podophyllotoxin derivative].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; KB Cells; Mouth Neoplasms; Podophyllotoxin; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins p21(ras); RNA, Messenger; Tumor Suppressor Protein p53 | 2011 |
Effects of epidermal growth factor receptor and insulin-like growth factor 1 receptor inhibition on proliferation and intracellular signaling in cutaneous SCCHN: potential for dual inhibition as a therapeutic modality.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Erlotinib Hydrochloride; Fluorescent Antibody Technique; Head and Neck Neoplasms; Humans; Insulin-Like Growth Factor Binding Protein 1; Podophyllotoxin; Protein Kinase Inhibitors; Quinazolines; Signal Transduction; Squamous Cell Carcinoma of Head and Neck | 2013 |
[Item 149--Epithelial and melanotic skin tumors: human papillomavirus (HPV) tumors].
Topics: Adult; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Child; Combined Modality Therapy; Condylomata Acuminata; Cryosurgery; Cryotherapy; Female; Gammapapillomavirus; Humans; Imiquimod; Immunocompromised Host; Laser Therapy; Lasers, Gas; Male; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Pregnancy Complications, Neoplastic; Risk; Skin Neoplasms; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaccination; Warts | 2012 |
Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1981 |
Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Podophyllotoxin; Uterine Cervical Neoplasms | 1984 |
Establishment of an etoposide-resistant human epithelial tumour cell line in vitro: characterization of patterns of cross-resistance and drug sensitivities.
Topics: Carcinoma, Squamous Cell; Cell Line; Cisplatin; DNA, Neoplasm; Drug Resistance; Etoposide; Fluorouracil; Humans; Podophyllotoxin; Teniposide; Tongue Neoplasms; Vincristine; X-Rays | 1984 |
Phase II study of etoposide in the treatment of esophageal carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Esophageal Neoplasms; Etoposide; Humans; Middle Aged; Podophyllotoxin | 1983 |
Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium).
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Middle Aged; Podophyllotoxin | 1982 |
Phase II trial of VP-16-213 in non-small-cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bone Marrow; Carcinoma, Squamous Cell; Digestive System; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1982 |
Preliminary study of the combination, dianhydrogalactitol, cis-diaminedichloroplatinum (II), and VP-16-213 in patients with advanced cancer.
Topics: Brain Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Pilot Projects; Podophyllotoxin; Sugar Alcohols | 1981 |
[Chemotherapy of non-small-cell bronchial cancer with a combination of Cis-diamminedichloroplatinum (II) and VP 16-213].
Topics: Adenocarcinoma; Body Weight; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Etoposide; Humans; Leukocyte Count; Lung Neoplasms; Podophyllotoxin; Vomiting | 1981 |
[In vitro comparison of podophyllotoxin analogues; etoposide, teniposide and NK 611 using human lung cancer cell lines].
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Division; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Podophyllotoxin; Teniposide; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1993 |
VM26 (NSC-122819): a clinical study in advanced cancer of the lung and ovary.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Teniposide; Thrombocytopenia | 1978 |
Cytotoxic agents from Bursera morelensis (Burseraceae): deoxypodophyllotoxin and a new lignan, 5'-desmethoxydeoxypodophyllotoxin.
Topics: Animals; Carcinoma, Squamous Cell; Drugs, Chinese Herbal; Humans; Leukemia, Experimental; Neoplasms, Experimental; Plants, Medicinal; Podophyllotoxin | 1977 |
VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Time Factors | 1978 |
[VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
Topics: Adenocarcinoma; Anaplasia; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Podophyllotoxin; Remission, Spontaneous; Vincristine | 1977 |
[Chemotherapeutic combinations of mutually potentiating drugs. 2-Application to the treatment of bronchial cancers].
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Squamous Cell; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Humans; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Vincristine | 1975 |
[A phase II study of oral VP-16 in primary lung cancer].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anorexia; Capsules; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin | 1985 |
[A phase II study of NK171 (etoposide)].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Alopecia; Anorexia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin | 1985 |
[A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Anorexia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Injections; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin | 1986 |
Teniposide in squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Middle Aged; Podophyllotoxin; Teniposide; Uterine Cervical Neoplasms | 1987 |
The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung.
Topics: Animals; Carcinoma, Squamous Cell; Cell Cycle; Cell Line; Cell Survival; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance; Etoposide; Lung Neoplasms; Podophyllotoxin; Teniposide | 1987 |
Phase II study of etoposide (VP-16) in the treatment of advanced head and neck cancer.
Topics: Alopecia; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Head and Neck Neoplasms; Humans; Leukopenia; Lymphatic Metastasis; Podophyllotoxin | 1985 |
GIANT CONDYLOMA AND VERRUCOUS CARCINOMA OF THE GENITAL AREA.
Topics: Buschke-Lowenstein Tumor; Carcinoma, Squamous Cell; Carcinoma, Verrucous; Genitalia, Male; Humans; Lymphatic Metastasis; Male; Neoplasms; Papilloma; Pathology; Penile Neoplasms; Podophyllin; Podophyllum; Scrotum; Skin Neoplasms; Surgical Procedures, Operative | 1965 |
[Proresid-methotrexate combination in chemotherapy of orofacial carcinoma].
Topics: Agranulocytosis; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Humans; Infections; Injections, Intra-Arterial; Leukopenia; Lip Neoplasms; Melanoma; Methotrexate; Mouth Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Tongue Neoplasms | 1970 |
Exfoliative cytology in following the effectiveness of chemotherapy of malignant neoplasms of the orofacial region.
Topics: Aged; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Cytodiagnosis; Facial Neoplasms; Female; Humans; Male; Mandibular Neoplasms; Medulloblastoma; Methods; Methotrexate; Middle Aged; Mouth Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum | 1971 |
[Resistance formation in the cytostatic treatment of carcinomas].
Topics: Adenocarcinoma; Autoradiography; Carcinoma, Squamous Cell; Cystadenoma; Female; Genital Neoplasms, Female; Granulosa Cell Tumor; Humans; Ovarian Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Tritium; Uterine Cervical Neoplasms; Uterine Neoplasms; Vulvar Neoplasms | 1969 |
[Viral diseases of the exernal female genitalia. 4. Condylomata acuminata and verrucae vulgares].
Topics: Adult; Anus Diseases; Anus Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Electrocoagulation; Female; Humans; Middle Aged; Papilloma; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Pyelonephritis; Rectal Diseases; Virus Diseases; Vulvar Neoplasms; Warts | 1970 |
The treatment of skin carcinoma with podophyllum derivatives.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Colchicine; Fluorouracil; Humans; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Skin Neoplasms | 1971 |
[Combines cytostatic treatment of malignant tumors. (Clinical histological report of 4 cases)].
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Facial Neoplasms; Humans; Laryngeal Neoplasms; Liver; Male; Middle Aged; Mitosis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Parotid Neoplasms; Pharyngeal Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Triaziquone | 1967 |
Relationship of podophyllin to carcinogenesis. A comparison of cytologic and histologic changes induced by podophyllin in the mouse cervix with those induced by 3,4 benzpyrene.
Topics: Animals; Antineoplastic Agents; Benzopyrenes; Carcinoma, Squamous Cell; Cervix Uteri; Female; Mice; Neoplasms, Experimental; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Uterine Cervical Neoplasms | 1966 |